Dr. Raez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 N Flamingo Rd
Suite 11
Pembroke Pines, FL 33028Phone+1 954-844-6868Fax+1 954-443-4747
Summary
- Luis E. Raez, MD, FACP, FCCP; is the Medical Director & Chief Scientific Officer of Memorial Cancer Institute at Memorial Health Care System in Florida and Director of the Thoracic Oncology Program. He was President of the Florida Society of Clinical Ocnology (FLASCO) from 2019-2021. He is also Clinical Professor of Medicine at Florida International University (FIU), Clinical Research Professor at Florida Atlantic University (FAU) and Visiting Professor of Medicine at Cayetano Heredia University in Peru.
He was an Associate Professor of Medicine, Epidemiology and Public Health, and a Co-Director of Thoracic Oncology at Sylvester Cancer Center/University of Miami for 10 years (2001-2011). He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer.
He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. Dr. Raez does translational research in the areas of cancer vaccines. He has been funded by NCI and the pharma industry. He has given oral presentations and lectures in national and international meetings in the US, Europe, Latinamerica and Asia.
He is American Board Certified in: Internal Medicine, Medical Oncology. He is Board Elegible in Hematology.
He is a member of AACR, ESMO, ASCO, IASLAC, ALLIANCE, NCCTG, ACCP, ACP, ACSG, FLASCO among other institutions.
Education & Training
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1999
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 1993 - 1996
- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1993 - 1994
- Cayetano Heredia UniversityClass of 1990
- University of Miami
Certifications & Licensure
- FL State Medical License 1996 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Listed in Who’s Who among Executives and Professionals Throughout the World 2009-Present, 2012
- Listed in Cambridge Who’s who 2007-present, 2012
- Join now to see all
Clinical Trials
- Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) Start of enrollment: 2004 Apr 01
- Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors Start of enrollment: 2004 Feb 01
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 23 citationsLiquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC).Luis E Raez, Kayla Brice, Katerine Dumais, Alejandro Lopez-Cohen, Delia Wietecha
Clinical Lung Cancer. 2023-03-01 - 1598 citationsEfficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen
The New England Journal of Medicine. 2018-02-21 - 346 citationsA phase I dose-escalation trial of 2-deoxy- d -glucose alone or combined with docetaxel in patients with advanced solid tumorsLuis E. Raez, Kyriakos P. Papadopoulos, A. Ricart, E. Gabriella Chiorean, Robert S. DiPaola
Cancer Chemotherapy and Pharmacology. 2013-02-01
Journal Articles
- Phase 2 study of bortezomib alone and in combination with docetaxel in advanced non-small cell lung cancer.Fanucchi MP, Fossella F, Belt F, Natale R, Fidias P, Carbone D, Govindan R, Raez LE, Robert F, Ribeiro M, Axelrod R, Kashala O, Sheng S, Schiller J, J Clin Oncol; 24(31):5025-33
- Stem cell research and the human embrion.Raez LE, Revista VE; 17 (50): 87-105
- Epidermal growth factor vaccine in non-small-cell lung cancer.Gonzalez Marinello GM, Santos ES, Raez LE, Expert Rev Anticancer Ther;12(4):439-45
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Immunotherapy for lung tumors.Podack, ER; Raez LE, J of Thor Onc 2(8). Supplement 4:S197-S198
- Accuracy of endobronchial ultrasound-directed transbronchial needle aspiration (EBUS-TBNA) in mediastinal staging in patients (pts) with non-small cell lung cancer (NS...Tupayachi MG, Hosein PJ, Nguyen DM, Thurer R, Garcia M, Raez LE, Donna E, J Clin Oncol 28:15s, suppl; abstr 7071
- Free circulating DNA by RT-PCR as predictor for chemotherapy response in newly diagnosed patients (pts) with advanced non-small cell lung cancer (NSCLC).Santos E, Talebi E, Raez LE, Quintero C, Walker G, Farias M, K. Ramachandran, E. Gordian, J. Gomez, R. Singal, J Clin Oncol 28, suppl; abstr e18107
- Join now to see all
Lectures
- Effect of oligometastatic disease management with stereotactic body radiation therapy on survival in patients with metastatic lung cancer.2019 ASCO Annual Meeting - 6/1/2019
- RNA-based biomarker signatures in plasma as an independent predictor of outcome to chemotherapy in lung, colon, and breast cancers: Correlation of relative PD-L1 expre...2019 ASCO Annual Meeting - 6/1/2019
- Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC).2019 ASCO Annual Meeting - 6/1/2019
- Join now to see all
Authored Content
- ESMO 2020'S Update on Lung Cancer TreatmentsSeptember 2020
Press Mentions
- Navigating the Treatment Landscape for ROS1+ NSCLCOctober 21st, 2024
- Advancing the Treatment of ROS1+ NSCLC: An Oncologist’s PerspectiveJuly 24th, 2024
- Repotrectinib Expands Treatment Options for Lung Cancers with ROS1 FusionsFebruary 16th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Other Languages
- Spanish
External Links
- Dr. Luis Raez: Medical Director - Memorial Cancer Institutehttps://www.youtube.com/watch?v=WrhhXZ4i3sk&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=36&t=2s
- Dr. Raez on the Role of Liquid Biopsies in Newly Diagnosed Lung Cancerhttps://www.youtube.com/watch?v=I62Klrkau_s&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=1&t=6s
- Options for Patients With Lung Cancer and Genetic Alterationshttps://www.youtube.com/watch?v=T0vDmtbD5WI&list=PLmoP2YoG6hfBBs6DtS6HyKx69olSk2Ow9&index=2
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: